The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection
Abstract
Nevirapine, a potent nonnucleoside reverse transcriptase inhibitor, produces a transient antiviral effect at < or = 200 mg/day due to the selection of resistant virus. To examine if higher levels of nevirapine could produce sustained antiviral activity, its safety, pharmacokinetics, and antiviral activity at 400 mg/day were studied in 21 patients. There was a rapid reduction in immune complex-dissociated p24 antigen and serum human immunodeficiency virus RNA concentration in all patients, and 8 of 10 patients had > 50% reduction at 8 weeks. Nevirapine-resistant virus was isolated from all subjects tested at 12 weeks: The mean plasma trough level (4.0 micrograms/mL [15.8 microM]) exceeded the mean IC50 of resistant virus. Rash developed in 48% of patients and was a dose-limiting toxicity factor in 6. These data suggest that clinical testing of potent antiviral compounds that select for drug-resistant virus is justified to determine if serum levels of drug sufficient to overcome resistant virus can be attained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Self-citationVolberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221401 · Cited by 1,283
Self-citationInhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Merluzzi, V. J., Hargrave, K. D., Labadia, M., Grozinger, K., Skoog, M., Wu, J. C., Shih, C.-K., Eckner, K., Hattox, S., Adams, J., et al. (1990) · Science · doi:10.1126/science.1701568 · Cited by 743
Self-citationNevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
Richman, D. D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S. A., Sullivan, J., Cheeseman, S., Barringer, K., & Pauletti, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1660-1666.1994 · Cited by 576
Self-citationRichman, D., Shih, C. K., Lowy, I., Rose, J., Prodanovich, P., Goff, S., & Griffin, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11241 · Cited by 393
Self-citationNunberg, J. H., Schleif, W. A., Boots, E. J., O'Brien, J. A., Quintero, J. C., Hoffman, J. M., Emini, E. A., & Goldman, M. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4887-4892.1991 · Cited by 363
Kahn, J. O., Lagakos, S. W., Richman, D. D., Cross, A., Pettinelli, C., Liou, S.-H., Brown, M., Volberding, P. A., Crumpacker, C. S., Beall, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270901 · Cited by 347
Self-citationHIV Inhibitors Targeted at the Reverse Transcriptase
DE CLERCQ, E. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.119 · Cited by 262
Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents
Richman, D. D. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1207 · Cited by 223
Self-citationSaag, M. S., Emini, E. A., Laskin, O. L., Douglas, J. A., Lapidus, W. I., Schleif, W. A., Whitley, R. J., HILDEBRAND, C. S., Byrnes, V. W., Kappes, J. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310073291502 · Cited by 156
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy
Chow, Y.-K., Hirsch, M., Merrill, D. P., Bechtel, L. J., Eron, J. J., Kaplan, J. C., & D’Aquila, R. T. (1993) · Nature · doi:10.1038/361650a0 · Cited by 154
Otto, M. J., Garber, S., Winslow, D. L., Reid, C. D., Aldrich, P. E., Jadhav, P., Patterson, C. E., Hodge, C. N., & Cheng, Y.-S. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7543 · Cited by 129
Koup, R. A., Merluzzi, V. J., Hargrave, K. D., Adams, J., Grözinger, K. G., Eclmer, R. J., & Sullivan, J. L. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.5.966 · Cited by 118
Self-citationCohen, K. A., Hopkins, J., Ingraham, R. H., Pargellis, C., Wu, J. C., Palladino, D. E. H., Kinkade, P., Warren, T. C., Rogers, S., & Adams, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98737-5 · Cited by 116
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans
Cheeseman, S. H., Hattox, S. E., McLaughlin, M. M., Koup, R. A., Andrews, C., Bova, C., Pav, J. W., Roy, T., Sullivan, J. L., & Keirns, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.178 · Cited by 102
Self-citationShih, C. K., Rose, J. M., Hansen, G. L., Wu, J. C., Bacolla, A., & Griffin, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9878 · Cited by 102
Cited by
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461
Self-citationStaszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Wainberg, M. A., Smith, D., Robinson, P., Hall, D., et al. (1998) · JAMA · doi:10.1001/jama.279.12.930 · Cited by 756
Self-citationvan Leth, F., Phanuphak, P., Ruxrungtham, K., Baraldi, E., Miller, S., Gazzard, B., Cahn, P., Lalloo, U., van der Westhuizen, I., Malan, D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15997-7 · Cited by 684
Self-citation
Metadata
- Authors
- Havlir, D., Cheeseman, S. H., Mclaughlin, M., Murphy, R., Erice, A., Spector, S. A., Greenough, T. C., Sullivan, J. L., Hall, D., Myers, M., Lamson, M., & Richman, D. D.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-03-01
- Volume
- 171
- Issue
- 3
- Pages
- 537-545
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2163828009
- Cited by
- 298
- References
- 16
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.